drugset / Trial / NCT01655108
Efficacy and Safety of Mesotherapy With Minoxidil 0.5%/2ml for Androgenetic Alopecia in Female Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
This study aims to investigate the effectiveness and safety of mesotherapy for the treatment of female pattern alopecia. * Sixty female subjects between 18 and 65 years diagnosed with female pattern hair loss will undergo mesotherapy sessions weekly for ten weeks. * One group will receive 0.5%/2ml minoxidil application and a control group will receive application of placebo (saline 0.9%). * Biopsy of the scalp, trichogram and trichoscopy (Fotofinder) will be performed before and 08 weeks after treatment as a method objective evaluation of the response
Timeline
- Start
- 2012-03
- Primary completion
- 2013-10
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Minoxidil | Small molecule | 0.5 % | Other |
| Comparator | Minoxidil | Small molecule | 2 ml | Other |